Advances in the Formulation and Assembly of Non-Cationic Lipid Nanoparticles for the Medical Application of Gene Therapeutics
Authors:
- Richard K. FisherRichard K. Fisher
- Phillip C. WestPhillip C. West
- Samuel I. Mattern-SchainSamuel I. Mattern-Schain
- Michael D. BestMichael D. Best
- Stacy S. KirkpatrickStacy S. Kirkpatrick
- Raymond A. DieterRaymond A. Dieter
- Joshua D. ArnoldJoshua D. Arnold
- Michael R. BuckleyMichael R. Buckley
- Michael M. McNallyMichael M. McNally
- Michael B. FreemanMichael B. Freeman
- Oscar H. GrandasOscar H. Grandas
- Deidra J. H. MountainDeidra J. H. Mountain
Open Access
- 23 March 2021
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 11 (3) , 825
Abstract
Lipid nanoparticles have become increasingly popular delivery platforms in the field of gene therapy, but bench-to-bedside success has been limited. Many liposomal gene vectors are comprised of synthetic cationic lipids, which are associated with lipid-induced cytotoxicity and immunogenicity. Natural, non-cationic PEGylated liposomes (PLPs) demonstrate favorable biocompatibility profiles but are not considered viable gene delivery vehicles due to inefficient nucleic acid loading and reduced cellular uptake. PLPs can be modified with cell-penetrating peptides (CPPs) to enhance the intracellular delivery of liposomal cargo but encapsulate leakage upon CPP-PLP assembly is problematic. Here, we aimed to identify parameters that overcome these performance barriers by incorporating nucleic acid condensers during CPP-PLP assembly and screening variable ethanol injection parameters for optimization. CPP-PLPs were formed with R8-amphiphiles via pre-insertion, post-insertion and post-conjugation techniques and liposomes were characterized for size, surface charge, homogeneity, siRNA encapsulation efficiency and retention and cell associative properties. Herein we demonstrate that pre-insertion of stearylated R8 into PLPs is an efficient method to produce non-cationic CPP-PLPs and we provide additional assembly parameter specifications for a modified ethanol injection technique that is optimized for siRNA encapsulation/retention and enhanced cell association. This assembly technique could provide improved clinical translation of liposomal based gene therapy applications.Keywords
This publication has 37 references indexed in Scilit:
- Engineering liposomal nanoparticles for targeted gene therapyGene Therapy, 2017
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systemsGene Therapy, 2017
- Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-responseBiomaterials, 2015
- Liposomes: Targeted and Controlled Delivery SystemDrug Delivery Letters, 2014
- Cationic lipids activate intracellular signaling pathwaysAdvanced Drug Delivery Reviews, 2012
- The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activationBiomaterials, 2010
- Stealth nanoparticles: High density but sheddable PEG is a key for tumor targetingJournal of Controlled Release, 2010
- Cationic lipids, lipoplexes and intracellular delivery of genesJournal of Controlled Release, 2006
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Cationic Liposomes Induce Macrophage Apoptosis through Mitochondrial PathwayArchives of Biochemistry and Biophysics, 2001